XENE Xenon Pharmaceuticals Inc
2,581
$39.31
$1.11
(2.75%)
| Watchers | 2,581 |
| 52-Wk Low | $27.99 |
| 52-Wk High | $50.99 |
| Market Cap | $3.05B |
| Volume | 196,955.00 |
| 52-Wk High | $50.99 |
| 52-Wk Low | $27.99 |
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • about 2 months ago
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will...
Share to Feed
This is a signal that XENE's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors bought 4,063 put options on the stock. This represents an...
This is a signal that XENE's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that XENE's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will...